NCT07064395

Bright Light Therapy on Sleep Health in Lung Cancer Patients

Bright Light Therapy to Reduce Sleep Disturbance and Biological Aging in Lung Cancer Patients

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: Henry Ford Health System · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The goal of this randomized intervention trial is to determine the effect of bright light therapy on sleep disturbance, as well as to investigate the impacts of bright light therapy on biological age measured by clinical biomarkers. The main questions it aims to answer are: * Does bright light therapy improve sleep patterns (i.e., sleep onset latency, sleep disturbance, and sleep efficiency) in lung cancer patients? * Can bright light therapy slow the rate of aging measured by biological age in lung cancer patients? Researchers will compare bright light therapy group to control group to see if bright light works to reduce sleep disturbance and decelerate biological aging. Participants will: * Receive bright light exposure or usual light exposure every day for 4 weeks * Get blood draw at the baseline and at 4 weeks for clinical biomarkers tests * Complete self-reported sleep, fatigue and stress surveys at the baseline and at 4 weeks * Keep a daily sleep log

Conditions

• Lung Cancers

Interventions

Type	Name	Description
OTHER	bright light	Lung cancer patients in the bright light arm will receive 12,000 lux bright light through light visor for 4 weeks.

Timeline

• Start date: 2025-06-09
• Primary completion: 2026-02-28
• Completion: 2026-02-28
• First posted: 2025-07-14
• Last updated: 2025-07-14

Locations

1 site across 1 country: United States